Stock listing
Frankfurt:D1C Airway Medix SA Aktie
German listing (Frankfurt) of Airway Medix SA · home listing GPW:AWM
Follow Airway Medix SA into a list and get an email when it puts out news.
Share price · FWB:D1C
€0.039 EUR +0.000 (+1.0%)
Close on Nov 20, 2026
- Day range
- €0.039 – €0.039 EURNov 20, 2026
- Market cap
- €4.47M EURAt the close on Nov 20, 2026 · price × 115.1M shares outstanding
- Traded on an average day
- €0 EURMedian day 0 shares · 57 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| GPW:AWM · Home | 0.238 PLN | +0.002 (+0.6%) | 27,137 | 0.239 | 0.239 | 0.227 | 0.236 | Close on Nov 20, 2026 |
| Frankfurt:D1C | €0.039 EUR | +0.000 (+1.0%) | — | €0.039 | €0.039 | €0.039 | €0.038 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:D1C · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.040 | 0.000 | 0.0% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.040 | 0.000 | 0.0% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.040 | 0.000 | 0.0% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.040 | 0.000 | 0.0% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.040 | -0.001 | -2.4% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.041 | 0.000 | 0.0% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.041 | 0.000 | 0.0% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.041 | 0.000 | 0.0% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.041 | -0.001 | -2.4% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.042 | 0.000 | 0.0% | €0.042 | €0.042 | €0.042 | 0 | |
| €0.042 | +0.002 | +5.0% | €0.042 | €0.042 | €0.042 | 0 | |
| €0.040 | +0.001 | +2.6% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.039 | -0.001 | -2.5% | €0.039 | €0.039 | €0.039 | 0 | |
| €0.040 | 0.000 | 0.0% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.040 | -0.001 | -2.4% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.041 | +0.001 | +2.5% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.040 | -0.001 | -2.4% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.041 | +0.001 | +2.5% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.040 | 0.000 | 0.0% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.040 | -0.001 | -2.4% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.041 | 0.000 | 0.0% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.041 | 0.000 | 0.0% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.041 | +0.001 | +2.5% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.040 | -0.001 | -2.4% | €0.040 | €0.040 | €0.040 | 0 | |
| €0.041 | 0.000 | 0.0% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.041 | -0.002 | -4.7% | €0.041 | €0.041 | €0.041 | 0 | |
| €0.043 | +0.001 | +2.4% | €0.043 | €0.043 | €0.043 | 0 | |
| €0.042 | -0.001 | -2.3% | €0.042 | €0.042 | €0.042 | 0 | |
| €0.043 | 0.000 | 0.0% | €0.043 | €0.043 | €0.043 | 0 | |
| €0.043 | -0.002 | -4.4% | €0.043 | €0.043 | €0.043 | 0 | |
| €0.045 | -0.002 | -4.3% | €0.045 | €0.045 | €0.045 | 0 | |
| €0.047 | +0.002 | +4.4% | €0.047 | €0.047 | €0.047 | 0 | |
| €0.045 | 0.000 | 0.0% | €0.045 | €0.045 | €0.045 | 0 | |
| €0.045 | 0.000 | 0.0% | €0.045 | €0.045 | €0.045 | 0 | |
| €0.045 | 0.000 | 0.0% | €0.045 | €0.045 | €0.045 | 0 | |
| €0.045 | 0.000 | 0.0% | €0.045 | €0.045 | €0.045 | 0 | |
| €0.045 | -0.003 | -6.3% | €0.045 | €0.045 | €0.045 | 0 | |
| €0.048 | 0.000 | 0.0% | €0.048 | €0.048 | €0.048 | 0 | |
| €0.048 | +0.002 | +4.3% | €0.048 | €0.048 | €0.048 | 0 | |
| €0.046 | 0.000 | 0.0% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.046 | 0.000 | 0.0% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.046 | 0.000 | 0.0% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.046 | -0.001 | -2.1% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.047 | +0.001 | +2.2% | €0.047 | €0.047 | €0.047 | 0 | |
| €0.046 | 0.000 | 0.0% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.046 | 0.000 | 0.0% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.046 | 0.000 | 0.0% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.046 | 0.000 | 0.0% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.046 | -0.001 | -2.1% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.047 | -0.001 | -2.1% | €0.047 | €0.047 | €0.047 | 0 | |
| €0.048 | -0.001 | -2.0% | €0.048 | €0.048 | €0.048 | 0 | |
| €0.049 | +0.002 | +4.3% | €0.049 | €0.049 | €0.049 | 0 | |
| €0.047 | 0.000 | 0.0% | €0.047 | €0.047 | €0.047 | 0 | |
| €0.047 | +0.001 | +2.2% | €0.047 | €0.047 | €0.047 | 0 | |
| €0.046 | -0.002 | -4.2% | €0.046 | €0.046 | €0.046 | 0 | |
| €0.048 | +0.001 | +2.1% | €0.048 | €0.048 | €0.048 | 0 | |
| €0.047 | -0.001 | -2.1% | €0.047 | €0.047 | €0.047 | 0 |
- Ticker
- Frankfurt:D1C
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
Latest news
Airway Medix SA on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 1 in all · newest Aug 15, 2020 · oldest 2020
Where Airway Medix SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| GPW:AWM · Home listing | GPW | Poland | PLN |
| Frankfurt:D1C · This page | Frankfurt | Germany | EUR |
| LSE:0RI2 | LSE | United Kingdom | PLN |
Valuation
EV/sales 278× against a median of 0.4×: the highest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 40.89M PLN
- P/E
- Loss
- EV/sales
- 278×
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- Revenue too small
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- Negative equity
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Airway Medix SA · GPW:AWM | US$6.73M | US$10.07M | n/a | 278× | n/a | n/a | n/a | n/a | n/a |
| ReNerve Limited · ASX:RNV | US$8.04M | US$7.05M | n/a | 20.9× | n/a | 3.8× | n/a | 0.0× | n/a |
| Lifeward Ltd. · NASDAQ:LFWD | US$7.94M | US$5.86M | n/a | 0.3× | n/a | 1.1× | −155.4% | 0.3× | 1.22 |
| IRIDEX Corporation · NASDAQ:IRIX | US$7.92M | US$11.69M | n/a | 0.2× | n/a | 3.0× | −6.9% | 2.8× | 0.90 |
| Clinical Laserthermia Systems AB Class B · OMXSTO:CLS_B | US$7.54M | US$7.16M | n/a | 5.8× | n/a | 1.6× | −314.6% | 0.0× | n/a |
| BioElectronics Corp. · OTC:BIEL | US$7.41M | US$23.70M | n/a | 46.4× | n/a | n/a | −104.3% | n/a | 2.45 |
| Surgical Innovations Group plc · LSE:SUN | US$6.71M | US$7.01M | n/a | 0.5× | n/a | 0.7× | −7.7% | 0.1× | n/a |
| Izotropic Corp. · CSE:IZO | US$6.30M | US$6.26M | n/a | n/a | n/a | n/a | n/a | n/a | 0.21 |
| Accuray Incorporated · NASDAQ:ARAY | US$6.20M | US$65.61M | n/a | 0.2× | n/a | 0.1× | −4.4% | 1.9× | 2.46 |
| NeuroOne Medical Technologies Corporation · NASDAQ:NMTC | US$5.94M | US$3.89M | n/a | 0.4× | n/a | 1.6× | −78.6% | 0.0× | 1.07 |
| Neola Medical AB · OMXSTO:NEOLA | US$5.46M | US$5.06M | n/a | n/a | n/a | 0.6× | n/a | 0.0× | n/a |
| Median of the others | US$7.06M | US$7.03M | 0.4× | 1.3× | −78.6% | 0.0× | 1.15 |
Team and board
| Officer | Role |
|---|---|
| Alicja Psiuk | Marketing Director, Distribution |
| Ernest Bucior | Chief Scientific Officer |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.00K | 12.0K | 12.0K | 95.0K | 6.00K | 257.0K | 294.0K | 921.0K | 57.0K | |
| Cost of revenue | 5.76M | 4.60M | 2.53M | 2.84M | 1.76M | 2.14M | 2.12M | 1.00K | 2.83M | 86.0K |
| Gross profit | -5.75M | -4.59M | 12.0K | -2.74M | 6.00K | 257.0K | -1.82M | 920.0K | -17.0K | -29.0K |
| Research and development | 12.1M | 357.0K | 1.23M | 586.0K | ||||||
| Selling, general and administrative | 1.44M | 1.91M | 1.61M | 2.87M | 2.83M | 1.66M | ||||
| Operating income | -7.23M | -6.06M | -2.77M | -2.96M | -28.2M | -2.26M | -1.69M | -2.63M | -3.91M | -2.75M |
| Depreciation and amortization | 84.0K | 82.0K | 2.65M | 228.5K | 0 | 0 | 182.0K | 58 | 17.0K | 15.0K |
| EBITDA | -7.15M | -5.98M | -126.0K | -2.73M | -28.2M | -2.26M | -1.50M | -2.63M | -3.90M | -2.73M |
| Interest expense | 1.91M | 6.16M | 3.11M | 1.84M | 1.51M | 767.0K | 155.0K | 209.0K | 352.0K | 456.0K |
| Income before tax | 1.75M | -11.7M | -3.28M | -37.4M | -9.37M | -1.99M | -1.20M | -2.00M | 780.0K | -3.05M |
| Income tax | 542.0K | -2.33M | 388.0K | 163.0K | 39.0K | 145.0K | -1.04M | |||
| Net income | 1.75M | -11.7M | -3.28M | -37.9M | -7.04M | -2.37M | -1.36M | -2.03M | 635.0K | -2.02M |
| Earnings per share, basic | 0.02 | -0.16 | -0.05 | -0.65 | -0.12 | -0.04 | -0.02 | -0.03 | 0.01 | -0.04 |
| Earnings per share, diluted | -0.12 | -0.04 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 127.0K | 2.11M | 655.0K | 1.00K | 29.0K | 2.21M | 707.0K | 1.05M | 3.42M | 445.0K |
| Short-term investments | 4.78M | 5.40M | 5.04M | 4.68M | 4.32M | 7.92M | 8.00M | |||
| Receivables | 995.0K | 1.17M | 844.0K | 268.0K | 510.0K | 780.0K | 1.34M | 6.43M | 1.67M | |
| Inventory | 73.0K | 0 | 332.0K | 220.0K | 191.0K | 514.0K | 78.0K | 182.0K | ||
| Current assets | 1.20M | 3.28M | 6.46M | 5.67M | 5.91M | 22.4M | 6.56M | 17.3M | 13.6M | 21.8M |
| Property, plant and equipment | 89.0K | 2.37M | 2.53M | 137.0K | 188.0K | 333.0K | ||||
| Total assets | 12.3M | 3.82M | 7.36M | 6.21M | 44.5M | 51.5M | 43.8M | 45.7M | 28.5M | 29.0M |
| Accounts payable | 2.12M | 932.0K | 1.11M | 3.83M | 3.79M | 2.10M | 1.83M | 1.97M | 497.0K | 444.0K |
| Current liabilities | 16.9M | 18.1M | 17.2M | 12.4M | 18.3M | 13.0M | 3.01M | 6.86M | 1.20M | 713.0K |
| Long-term debt | 0 | 6.61M | 0 | 6.80M | 131.0K | 117.0K | 639.0K | 2.53M | ||
| Total debt | 11.4M | 21.3M | 14.5M | 14.6M | 13.4M | 10.4M | 3.75M | 4.06M | 2.53M | |
| Total liabilities | 19.5M | 28.1M | 20.6M | 19.6M | 20.6M | 20.8M | 10.9M | 11.6M | 3.25M | 4.68M |
| Shareholders' equity | -8.50M | -24.3M | -13.2M | -15.2M | 23.9M | 30.7M | 32.8M | 34.0M | 25.2M | 24.3M |
| Shares outstanding | 93.3M | 73.7M | 61.1M | 58.4M | 58.4M | 58.4M | 58.4M | 58.4M | 58.4M | 54.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3.38M | -7.59M | -4.20M | -442.0K | -5.85M | -2.25M | 4.98M | -3.11M | -3.69M | -3.03M |
| Capital spending | -237.0K | -19.0K | 0 | -130.0K | 0 | -7.00K | -6.72M | -3.32M | -5.15M | -5.46M |
| Free cash flow | -3.62M | -7.61M | -4.20M | -572.0K | -5.85M | -2.25M | -1.74M | -6.43M | -8.84M | -8.48M |
| Cash from investing | -237.0K | -72.0K | -130.0K | 0 | -5.02M | -6.72M | -3.32M | 8.80M | -5.46M | |
| Cash from financing | 1.62M | 9.13M | 4.85M | 550.0K | 3.71M | 8.73M | 1.40M | 4.06M | -2.01M | 8.49M |
| Share buybacks | -25.0K | 10.1M | ||||||||
| Change in cash | -1.99M | 1.46M | 654.0K | -25.0K | -2.19M | 1.51M | -345.0K | -2.37M | 2.97M | 91.0K |
Cap table
Built by 6ix from Airway Medix SA’s releases
- Common shares
- 115,110,444
- Fully diluted
- 115,110,444
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 115,110,444 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 115,110,444 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alicja Psiuk | Marketing Director, Distribution · Since at least Nov 4, 2026 |
| Ernest Bucior | Chief Scientific Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Airway Medix SA.